tiprankstipranks
Cytosorbents Corp (CTSO)
NASDAQ:CTSO

Cytosorbents (CTSO) Cash flow

453 Followers

Cytosorbents Cash Flow

CTSO's free cash flow for Q3 2023 was $―. For the 2023 fiscal year, CTSO's free cash flow was decreased by $-16.40M and operating cash flow was $-5.21M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Operating Cash Flow
$ -20.59M$ -28.23M$ -14.01M$ -5.61M$ -16.76M$ -10.84M
Investing Cash Flow
$ -1.01M$ -6.46M$ -4.28M$ -1.68M$ -1.52M$ -1.52M
Financing Cash Flow
$ 7.26M$ 4.96M$ 715.20K$ 66.35M$ 8.18M$ 17.47M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 68.68M$ 23.83M$ 53.83M$ 71.42M$ 12.23M$ 22.37M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 275.57K--$ 1.13M$ 1.06M$ 891.39K
Issuance Of Capital Stock
---$ 80.21M$ 673.65K$ 14.13M
Issuance Of Debt
$ 5.00M$ 5.00M-$ 1.41M$ 5.00M$ 666.67K
Repayment Of Debt
---$ -16.41M$ 0.00$ -666.67K
Free Cash Flow
$ -16.13M$ -34.69M$ -18.29M$ -7.29M$ -18.28M$ -12.36M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Cytosorbents Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis